Fig. 1From: The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergenceSingle Nucleotide Polymorphisms (SNP) in each of the Muguga Cocktail component T. parva stocks relative to the reference T. parva Muguga isolate. a) Number of base pairs in the reference T. parva Muguga genome assembly with no read coverage from each of the three isolates. SNPs cannot be identified in this fraction of the genome, respectively 0.55Â % (45,837Â bp), 0.29Â % (24,439Â bp) and 5.61Â % (466,092Â bp) of the genome, in the comparisons with Muguga clone 2, Serengeti-transformed and Kiambu5. b) Identified SNPs unique to, and shared among, Muguga clone 2, Kiambu5, and Serengeti-transformed isolatesBack to article page